Glossary
NCD 20.29
The Medicare National Coverage Determination that governs HBOT coverage.
NCD 20.29 is Medicare's National Coverage Determination for hyperbaric oxygen therapy. It lists the specific conditions Medicare covers and the clinical criteria that must be documented — the reference point for HBOT reimbursement.
More terms
Stem cell mobilization
HBOT's ability to release stem cells from bone marrow into circulation.
Angiogenesis
The growth of new blood vessels — a key long-term effect of HBOT.
HIF-1α
A cellular oxygen-sensing protein involved in healing signals.
Air break
A scheduled pause breathing normal air during a session to prevent oxygen toxicity.